Lee Chung is a Neurology physician affiliated with University of Utah. OpenAlex indexes 33 publications with 899 citations (h-index 10); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
175 N Medical Dr East
Salt Lake City, UT 841320001
Telephone
801-581-2121Provider last certified this registry record 12 Nov 2021.
Clinical trials
- Combined Exercise and Nutrition Intervention for Possible Sarcopenia Among Older Adults in Primary Care
Sponsor: Kyunghee University Medical Center
- DeciFace: Decipher the Influence of Ethnic Backgrounds on the Facial Dysmorphic Features of Rare Mendelian Disorders
Sponsor: National Taiwan University Hospital
- Long-term Efficacy of Carglumic Acid in Organic Acidemia.
Sponsor: National Taiwan University Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Ipsen Pharma SASProgram year20245 payments$11,908openpaymentsdata.cms.gov ↗
- Ipsen Biopharmaceuticals, IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
33.3%Factor Xa inhibitor18.3%Eliquis100%Part D<11 patientsPhosphodiesterase 3 Inhibitor15.1%Cilostazol100%Part D<11 patientsCardiovascular
29%Statin29%Rosuvastatin Calcium100%Part D≥11 patientsNervous system
25.8%Aromatic Amino Acid Decarboxylation Inhibitor14%Carbidopa-Levodopa100%Part D<11 patientsTricyclic Antidepressant11.8%Amitriptyline Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Enhancement within the orbits and superficial temporal artery: MRI clues to the diagnosis of giant cell arteritis
American Journal of Ophthalmology Case Reports
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Colman, MD
University of Utah
Michael Varner, MD
University of Utah
James Fang
University of Utah
Wallace Akerley, MD
University of Utah
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”